1,25-Dihydroxyvitamin D3 attenuates IL-1β secretion by suppressing NLRP1 inflammasome activation by upregulating the NRF2-HO-1 pathway in epidermal keratinocytes

Abstract

The nucleotide-binding oligomerization domain-like receptor family pyrin domain-containing protein (NLRP) inflammasome is a key inflammatory signaling pathway activated via a two-step signaling process consisting of priming and activation steps. Several studies have shown that 1,25-dihydroxyvitamin D3 (1,25(OH) 2 VD 3 ) inhibits the priming step required for NLRP3 inflammasome activation in immune cells. However, as activating the NLRP1 inflammasome in keratinocytes does not necessarily require a priming step, whether 1,25(OH) 2 VD 3 inhibits NLRP1 activation in unprimed keratinocytes is currently unknown. In this study, we showed that 1,25(OH) 2 VD 3 inhibits nigericin-induced NLRP1 inflammasome activation in unprimed keratinocytes. 1,25(OH) 2 VD 3 suppressed nigericin-induced interleukin-1β (IL-1β) secretion and caspase-1 activation in human primary keratinocytes. In addition, 1,25(OH) 2 VD 3 significantly inhibited the formation of apoptosis-associated speck-like protein containing a caspase recruitment domain (ASC) oligomers and specks, but not caspase-1 enzymatic activity, suggesting that 1,25(OH) 2 VD 3 prevents NLRP1-ASC complex assembly in keratinocytes. Vitamin D receptor (VDR)-knockdown abolished the inhibitory effects of 1,25(OH) 2 VD 3 on nigericin-induced ASC oligomerization and IL-1β secretion, suggesting that 1,25(OH) 2 VD 3 suppresses inflammasome activation via VDR signaling. Furthermore, nigericin induced K + efflux and cellular reactive oxygen species (ROS) production, and 1,25(OH) 2 VD 3 pretreatment suppressed nigericin-induced ROS production. 1,25(OH) 2 VD 3 increased the expression of both nuclear factor erythroid 2-related factor 2 (NRF2) and heme oxygenase-1 (HO-1), whereas HO-1 inhibition or NRF2 and HO-1 knockdown abrogated the inhibitory effects of 1,25(OH) 2 VD 3 on IL-1β secretion. Our results indicate that 1,25(OH) 2 VD 3 inhibits nigericin-induced activation step of NLRP1 inflammasome activation in unprimed keratinocytes. Our findings reveal the mechanism underlying the inhibitory effect of 1,25(OH) 2 VD 3 , which involves NRF2-HO-1 pathway activation through the VDR, providing further insight into the potential function of 1,25(OH) 2 VD 3 as a therapeutic agent for inflammasome-related skin diseases.

Lycopene attenuates the inflammation and apoptosis in aristolochic acid nephropathy by targeting the Nrf2 antioxidant system

“…It is known that accumulated ROS are able to activate TNF-α and stabilize its activity after the oxidative stress pathway is activated [ 66 ]. TNF-α can promotes the secretion of IL-1β in vivo [ 67 ]. In resting cells, NF-κB-p65 is inactivated by binding an inhibitory-κB (IκB) protein [ 17 ].…”

Mitochondrial RNA stimulates beige adipocyte development in young mice

“…Our NGS analysis revealed prominent expression of VDR-controlled gene networks in young adipocytes (Fig. 4a), and VDR is known to suppress cytosolic RNA-induced IRF7 expression 53,54 and the IFN response 55,56 . The transcriptional activity of VDR was confirmed by the pattern of VDR-controlled gene expression in young adipocytes (Fig.…”

NLRP1 Inflammasome Activation in Keratinocytes: Increasing Evidence of Important Roles in Inflammatory Skin Diseases and Immunity

“…Nigericin is a bacterial toxin activating NLRP3 in immune cells and NLRP1 in KCs and causes potassium ion efflux, calcium ion influx, and generation of ROS in treated cells (Fenini et al, 2018b;He et al, 2016;Nakajo et al, 2021). All these three events are also required for UVB-induced NLRP1 activation in HPKs (Feldmeyer et al, 2007).…”